Literature DB >> 27808149

Editorial: Reflux and Laryngeal Symptoms: A Sea of Confusion.

Michael F Vaezi1.   

Abstract

Chronic laryngeal symptoms are often attributed to gastroesophageal reflux disease based on nonspecific testing by laryngoscopy resulting in overdiagnosis of this condition. Identifying optimal means by which we can diagnose reflux in patients with chronic laryngeal symptoms is an unmet clinical area. One such technique might be measurement of oropharyngeal acid exposure employing a novel pH monitoring device. We outline the strengths and limitations of this new technology relative to the observational cohort study by Yadlapti et al. published in this issue of the Journal.

Entities:  

Mesh：

Year:  2016        PMID： 27808149     DOI： 10.1038/ajg.2016.315

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


  10 in total

1.  Benefit of acid-suppressive therapy in chronic laryngitis: the devil is in the details.

Authors:  Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2010-06-01       Impact factor: 11.382

2.  Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux.

Authors:  Oliver Reichel; Holger Dressel; Katrin Wiederänders; Wolfgang J Issing
Journal:  Otolaryngol Head Neck Surg       Date:  2008-09       Impact factor: 3.497

3.  High economic burden of caring for patients with suspected extraesophageal reflux.

Authors:  David O Francis; Jennifer A Rymer; James C Slaughter; Yash Choksi; Pawina Jiramongkolchai; Evbu Ogbeide; Christopher Tran; Marion Goutte; C Gaelyn Garrett; David Hagaman; Michael F Vaezi
Journal:  Am J Gastroenterol       Date:  2013-04-02       Impact factor: 10.864

4.  Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials.

Authors:  Mohammed A Qadeer; Christopher O Phillips; A Rocio Lopez; David L Steward; J Pieter Noordzij; John M Wo; Maria Suurna; Thomas Havas; Colin W Howden; Michael F Vaezi
Journal:  Am J Gastroenterol       Date:  2006-10-13       Impact factor: 10.864

5.  An oropharyngeal pH monitoring device to evaluate patients with chronic laryngitis.

Authors:  E S Yuksel; J C Slaughter; N Mukhtar; M Ochieng; G Sun; M Goutte; S Muddana; C Gaelyn Garrett; M F Vaezi
Journal:  Neurogastroenterol Motil       Date:  2013-03-18       Impact factor: 3.598

Review 6.  Extraesophageal manifestations of gastroesophageal reflux disease.

Authors:  Christopher Hom; Michael F Vaezi
Journal:  Gastroenterol Clin North Am       Date:  2012-12-23       Impact factor: 3.806

7.  Oropharyngeal pH monitoring for laryngopharyngeal reflux: is it a reliable test before therapy?

Authors:  Cristian Vailati; Giorgia Mazzoleni; Stefano Bondi; Mario Bussi; Pier Alberto Testoni; Sandro Passaretti
Journal:  J Voice       Date:  2012-11-15       Impact factor: 2.009

8.  Oropharyngeal pH Testing Does Not Predict Response to Proton Pump Inhibitor Therapy in Patients with Laryngeal Symptoms.

Authors:  Rena Yadlapati; John E Pandolfino; Alcina K Lidder; Nadine Shabeeb; Diana-Marie Jaiyeola; Christopher Adkins; Neelima Agrawal; Andrew Cooper; Caroline P E Price; Jody D Ciolino; Andrew J Gawron; Stephanie S Smith; Michiel Bove; Bruce K Tan
Journal:  Am J Gastroenterol       Date:  2016-04-19       Impact factor: 10.864

9.  Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux.

Authors:  Gregory J Wiener; Ross Tsukashima; Colleen Kelly; Erich Wolf; Molly Schmeltzer; Charles Bankert; Lauren Fisk; Michael Vaezi
Journal:  J Voice       Date:  2008-05-12       Impact factor: 2.009

10.  Validity and reliability of the reflux symptom index (RSI).

Authors:  Peter C Belafsky; Gregory N Postma; James A Koufman
Journal:  J Voice       Date:  2002-06       Impact factor: 2.009
  10 in total
  1 in total

1.  Response to Song et al.

Authors:  Rena Yadlapati; John E Pandolfino; Bruce K Tan
Journal:  Am J Gastroenterol       Date:  2017-05       Impact factor: 10.864
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.